Search research articles
Contact Us
Filters
Showing results (281-290 of 317) with videos related to
Page
of 32
Sort By:
Annals of Hematology
|
March 4, 2003
Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia
J Schetelig, C Thiede, M Bornhäuser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2000
Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies
M E Scheulen, R A Hilger, C Oberhoff, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
April 12, 1996
[Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group]
G Hübner, H Link, P Schönrock-Nabulsi, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
December 9, 2003
Liquid chromatographic method for detection and quantitation of STI-571 and its main metabolite N-desmethyl-STI in plasma, urine, cerebrospinal fluid, culture medium and cell preparations
E Schleyer, S Pursche, C H Köhne, et al.
Journal of Internal Medicine
|
October 14, 2017
What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?
O Ringdén, M Labopin, B Sadeghi, et al.
Leukemia
|
November 28, 2002
Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease
R Arnold, G Massenkeil, M Bornhäuser, et al.
Clinical and Experimental Immunology
|
January 23, 2016
Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation
C S Link, A Eugster, F Heidenreich, et al.
Leukemia
|
January 21, 2006
Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia
M Ritter, D Kattmann, S Teichler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 4, 2011
Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patients
U Brunnberg, M Mohr, R Noppeney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 11, 2016
Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†
S P Robinson, A Boumendil, H Finel, et al.
Page
of 32
Search research articles
Search
Showing results (281-290 of 317) with videos related to
Sort By:
Page
of 32
Annals of Hematology
|
March 4, 2003
Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia
J Schetelig, C Thiede, M Bornhäuser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2000
Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies
M E Scheulen, R A Hilger, C Oberhoff, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
April 12, 1996
[Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group]
G Hübner, H Link, P Schönrock-Nabulsi, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
December 9, 2003
Liquid chromatographic method for detection and quantitation of STI-571 and its main metabolite N-desmethyl-STI in plasma, urine, cerebrospinal fluid, culture medium and cell preparations
E Schleyer, S Pursche, C H Köhne, et al.
Journal of Internal Medicine
|
October 14, 2017
What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?
O Ringdén, M Labopin, B Sadeghi, et al.
Leukemia
|
November 28, 2002
Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease
R Arnold, G Massenkeil, M Bornhäuser, et al.
Clinical and Experimental Immunology
|
January 23, 2016
Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation
C S Link, A Eugster, F Heidenreich, et al.
Leukemia
|
January 21, 2006
Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia
M Ritter, D Kattmann, S Teichler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 4, 2011
Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patients
U Brunnberg, M Mohr, R Noppeney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 11, 2016
Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†
S P Robinson, A Boumendil, H Finel, et al.
Page
of 32